EndMT in CCM1-ablated endothelial cells is mediated by the up-regulation of Transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signalling, and the consequent EndMT activation results crucial in the onset and progression of CCM disease [19]. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.